Should I cease running and heavy weight‑lifting while experiencing acute withdrawal symptoms (dizziness, light‑headedness, fatigue, anxiety, reduced coordination) after abruptly stopping escitalopram and trazodone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Exercise During Acute Antidepressant Withdrawal

You should temporarily reduce the intensity of running and heavy weight-lifting—or pause them entirely—until your acute withdrawal symptoms (especially dizziness, light-headedness, and reduced coordination) resolve, then gradually resume as tolerated.

Rationale for Activity Modification

Safety Concerns with Current Symptoms

  • Dizziness, light-headedness, and reduced coordination are classic features of SSRI/SARI discontinuation syndrome and create significant fall and injury risk during activities requiring balance, rapid movements, or heavy loads 1, 2.

  • Escitalopram withdrawal commonly produces dizziness (reported in 44% of patients), confusion, trouble concentrating, and sensory disturbances that directly impair the motor control and spatial awareness needed for safe exercise 3, 4.

  • Trazodone discontinuation can cause similar symptoms including dizziness, anxiety, agitation, and sensory disturbances that compound the risk when combined with escitalopram withdrawal 5, 6, 7.

  • Operating hazardous machinery or performing tasks requiring mental/physical coordination is specifically cautioned against during withdrawal states due to cognitive and motor impairment 5.

Withdrawal Syndrome Characteristics

  • Your symptoms represent antidepressant discontinuation syndrome, characterized by dizziness, fatigue, anxiety, sensory disturbances, and reduced coordination following abrupt cessation of shorter-acting SSRIs like escitalopram and serotonergic agents like trazodone 1, 2.

  • These withdrawal symptoms typically emerge within days of discontinuation and generally resolve within 1–3 weeks, though they can persist longer depending on dose and duration of use 4, 7.

  • Higher doses and plasma concentrations of escitalopram significantly increase the risk and severity of discontinuation symptoms, making very slow tapering essential rather than abrupt cessation 3.

  • Trazodone's short half-life and effects on serotonergic/noradrenergic systems necessitate very slow tapering rates to avoid withdrawal manifestations 6.

Specific Exercise Recommendations

During Acute Withdrawal (Current Phase)

  • Avoid heavy weight-lifting entirely while experiencing dizziness and reduced coordination, as the risk of dropping weights, losing balance under load, or sustaining musculoskeletal injury is substantially elevated 2, 5.

  • Cease running or reduce to light walking until vestibular symptoms (dizziness, light-headedness) resolve, as these symptoms increase fall risk and can worsen with rapid head movements or cardiovascular exertion 1, 4.

  • Substitute with low-risk activities such as stationary cycling (where falling is less likely), gentle stretching, or supervised walking on flat surfaces until coordination normalizes 5.

Gradual Resumption Strategy

  • Resume light aerobic exercise first (walking, slow cycling) once dizziness subsides for 2–3 consecutive days, monitoring for symptom recurrence 4, 7.

  • Reintroduce resistance training at 50% of your previous intensity only after aerobic exercise is well-tolerated for one week without symptom exacerbation 8.

  • Progress gradually over 2–4 weeks back to your baseline exercise intensity, stopping immediately if withdrawal symptoms re-emerge 8, 7.

Important Clinical Considerations

Why Abrupt Cessation Was Problematic

  • Escitalopram and trazodone both require gradual dose reduction rather than abrupt discontinuation to minimize withdrawal symptoms 1, 2, 5.

  • Paroxetine, fluvoxamine, and sertraline are most associated with discontinuation syndrome among SSRIs, but escitalopram can also produce significant symptoms, particularly at higher doses 1.

  • The recommended tapering approach is approximately 25% dose reduction every 1–2 weeks, extending to several months for long-term users 9.

Distinguishing Withdrawal from Relapse

  • Withdrawal symptoms appear within days of discontinuation and are self-limiting (resolving in 1–3 weeks), whereas depression relapse develops more gradually over weeks to months 10, 4.

  • Your symptom cluster (dizziness, light-headedness, fatigue, anxiety, reduced coordination) is classic for discontinuation syndrome rather than depression recurrence 1, 2, 4.

Exercise Withdrawal vs. Medication Withdrawal

  • Stopping regular running can produce its own "withdrawal syndrome" with increased depression, anxiety, somatic symptoms, and feelings of strain within 1–2 weeks 8.

  • However, medication withdrawal symptoms (especially dizziness and coordination problems) pose immediate safety risks that take precedence over maintaining exercise continuity 2, 5.

  • The depression from exercise cessation develops more gradually (over 2 weeks) compared to medication withdrawal (within days), allowing time to address acute safety concerns first 8, 4.

Management of Current Situation

Immediate Steps

  • Contact your prescribing physician immediately to discuss reinstituting a gradual taper rather than continuing abrupt cessation, as this will minimize symptom duration and severity 2, 7.

  • Resuming the previously prescribed dose may be necessary if symptoms are intolerable, followed by a slower, physician-supervised taper 2.

  • Monitor for worsening symptoms including severe dizziness, confusion, seizures, or any signs of serotonin syndrome (though less likely during withdrawal) 1, 2.

Supportive Measures

  • Ensure adequate hydration and avoid sudden postural changes (stand slowly from sitting/lying) to minimize orthostatic symptoms that compound medication-related dizziness 5.

  • Maintain sleep hygiene and consider short-term use of supportive agents (if prescribed by your physician) such as low-dose trazodone for insomnia or clonidine for autonomic symptoms during a proper taper 11.

  • Avoid operating vehicles or machinery until coordination and alertness fully normalize 5.

Related Questions

What are the likely withdrawal symptoms and recommended management for feeling off on the first day after abruptly discontinuing escitalopram (Lexapro) and trazodone?
Could escitalopram (Lexapro) and trazodone be causing my urinary urgency and frequency?
Can a patient with depression or anxiety take Lexapro (escitalopram) and Trazodone together?
I am an adult who took escitalopram 5 mg daily for about seven weeks, tapered off and experienced SSRI discontinuation syndrome, then restarted 5 mg but still have persistent generalized anxiety, derealization, hyper‑awareness, and fear of losing reality for ten weeks; is it safe to increase the escitalopram dose to 7.5 mg (or up to the standard 10 mg) to improve symptoms without causing further destabilization?
Does trazodone clear from the bloodstream after discontinuation, and how long does it remain detectable?
What are the recommended guidelines for managing a school‑aged child (5–12 years) exposed to indoor environmental mold?
A female patient reports occasional dyspnea and a 15‑lb weight gain while taking escitalopram (Lexapro), propranolol, anastrozole, goserelin (Zoladex) and omeprazole; what could be causing these symptoms and what work‑up is recommended?
What are the adverse effects associated with lisinopril?
Is there a doxycycline formulation available in a 100 µg dose?
When switching glucagon‑like peptide‑1 (GLP‑1) receptor agonists, should the new medication be started at the lower end of its dosing range?
My TSH is 10 mIU/L while taking Armour Thyroid (desiccated thyroid) 180 µg daily; what should I do?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.